293 related articles for article (PubMed ID: 11137086)
1. Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits.
Rikitake Y; Kawashima S; Takeshita S; Yamashita T; Azumi H; Yasuhara M; Nishi H; Inoue N; Yokoyama M
Atherosclerosis; 2001 Jan; 154(1):87-96. PubMed ID: 11137086
[TBL] [Abstract][Full Text] [Related]
2. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits.
Mitani H; Egashira K; Kimura M
Pharmacol Res; 2003 Nov; 48(5):417-27. PubMed ID: 12967585
[TBL] [Abstract][Full Text] [Related]
4. Preservation of endothelium-dependent and Nomega-nitro-L-arginine methyl ester- and indomethacin-resistant arterial relaxation in high-cholesterol-diet fed rabbits by treatment with fluvastatin, an HMG-CoA reductase inhibitor.
Mitani H; Kimura M
J Cardiovasc Pharmacol; 2003 Jul; 42(1):55-62. PubMed ID: 12827027
[TBL] [Abstract][Full Text] [Related]
5. Preservation of endothelial function by the HMG-CoA reductase inhibitor fluvastatin through its lipid-lowering independent antioxidant properties in atherosclerotic rabbits.
Mitani H; Egashira K; Ohashi N; Yoshikawa M; Niwa S; Nonomura K; Nakashima A; Kimura M
Pharmacology; 2003 Jul; 68(3):121-30. PubMed ID: 12784083
[TBL] [Abstract][Full Text] [Related]
6. Fluvastatin, an HMG-CoA reductase inhibitor, protects LDL from oxidative modification in hypercholesterolemic rabbits.
Yasuhara M; Suzumura K; Tanaka K; Takahashi M; Aoki S; Odawara A; Narita H; Suzuki T
Biol Pharm Bull; 2000 May; 23(5):570-4. PubMed ID: 10823666
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits.
Mitani H; Bandoh T; Ishikawa J; Kimura M; Totsuka T; Hayashi S
Br J Pharmacol; 1996 Nov; 119(6):1269-75. PubMed ID: 8937733
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of amlodipine and fluvastatin on the deposition of advanced glycation end products in aortic wall of cholesterol and fructose-fed rabbits.
Akira K; Amano M; Okajima F; Hashimoto T; Oikawa S
Biol Pharm Bull; 2006 Jan; 29(1):75-81. PubMed ID: 16394514
[TBL] [Abstract][Full Text] [Related]
9. Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress.
Yamaguchi Y; Matsuno S; Kagota S; Haginaka J; Kunitomo M
Eur J Pharmacol; 2002 Feb; 436(1-2):97-105. PubMed ID: 11834252
[TBL] [Abstract][Full Text] [Related]
10. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation.
Keaney JF; Xu A; Cunningham D; Jackson T; Frei B; Vita JA
J Clin Invest; 1995 Jun; 95(6):2520-9. PubMed ID: 7769097
[TBL] [Abstract][Full Text] [Related]
11. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro.
Suzumura K; Yasuhara M; Tanaka K; Suzuki T
Biochem Pharmacol; 1999 Mar; 57(6):697-703. PubMed ID: 10037456
[TBL] [Abstract][Full Text] [Related]
13. Low-dose fluvastatin prevents the functional alterations of endothelium induced by short-term cholesterol feeding in rabbit carotid artery.
Sevin G; Akcay YD; Ozsarlak-Sozer G; Yasa M
ScientificWorldJournal; 2012; 2012():671728. PubMed ID: 22547992
[TBL] [Abstract][Full Text] [Related]
14. [Early intervention on atherosclerosis by fluvastatin and lectin-like oxidized low-density lipoprotein receptor-1 expression in atherosclerotic arteries in immature rabbits].
Yu YH; Wang Y; Chen Y; Liu ZZ; Sun SZ; Meng XH
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):762-6. PubMed ID: 16255856
[TBL] [Abstract][Full Text] [Related]
15. Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy.
Aviram M; Hussein O; Rosenblat M; Schlezinger S; Hayek T; Keidar S
J Cardiovasc Pharmacol; 1998 Jan; 31(1):39-45. PubMed ID: 9456275
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein.
Suzumura K; Tanaka K; Yasuhara M; Narita H
Biol Pharm Bull; 2000 Jul; 23(7):873-8. PubMed ID: 10919369
[TBL] [Abstract][Full Text] [Related]
17. Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin.
Yamaguchi Y; Matsuno S; Kagota S; Haginaka J; Kunitomo M
Atherosclerosis; 2004 Feb; 172(2):259-65. PubMed ID: 15019535
[TBL] [Abstract][Full Text] [Related]
18. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza.
Wu YJ; Hong CY; Lin SJ; Wu P; Shiao MS
Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):481-6. PubMed ID: 9514418
[TBL] [Abstract][Full Text] [Related]
19. Antioxidative potential of fluvastatin via the inhibition of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity.
Bandoh T; Sato EF; Mitani H; Nakashima A; Hoshi K; Inoue M
Biol Pharm Bull; 2003 Jun; 26(6):818-22. PubMed ID: 12808293
[TBL] [Abstract][Full Text] [Related]
20. Fluvastatin suppresses atherosclerotic progression, mediated through its inhibitory effect on endothelial dysfunction, lipid peroxidation, and macrophage deposition.
Bandoh T; Mitani H; Niihashi M; Kusumi Y; Kimura M; Ishikawa J; Totsuka T; Sakurai I; Hayashi S
J Cardiovasc Pharmacol; 2000 Jan; 35(1):136-44. PubMed ID: 10630744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
